Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Immatics (IMTX) Cash & Equivalents (2022 - 2025)

Immatics' Cash & Equivalents history spans 4 years, with the latest figure at $402.7 million for Q4 2025.

  • For Q4 2025, Cash & Equivalents rose 59.16% year-over-year to $402.7 million; the TTM value through Dec 2025 reached $402.7 million, up 59.16%, while the annual FY2025 figure was $390.8 million, 54.48% up from the prior year.
  • Cash & Equivalents for Q4 2025 was $402.7 million at Immatics, up from $253.0 million in the prior quarter.
  • Across five years, Cash & Equivalents topped out at $402.7 million in Q4 2025 and bottomed at $132.6 million in Q1 2024.
  • The 4-year median for Cash & Equivalents is $207.8 million (2024), against an average of $221.9 million.
  • The largest annual shift saw Cash & Equivalents rose 7.63% in 2024 before it soared 59.16% in 2025.
  • A 4-year view of Cash & Equivalents shows it stood at $151.5 million in 2022, then skyrocketed by 55.13% to $235.1 million in 2023, then increased by 7.63% to $253.0 million in 2024, then skyrocketed by 59.16% to $402.7 million in 2025.
  • Per Business Quant, the three most recent readings for IMTX's Cash & Equivalents are $402.7 million (Q4 2025), $253.0 million (Q4 2024), and $207.8 million (Q3 2024).